EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity—Reply

Louis J Aronne, SURMOUNT-4 Investigators

JAMA · 21.05.2024 · 331 (19) · 1676

DOI: 10.1001/jama.2024.2603 ↗

Kurz gefasst

Leserbrief in der Zeitschrift JAMA, erschienen am 21.05.2024. Verfasst von Louis J Aronne und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes, and Metabolism, Weill Cornell Medical College, New York, New York. Hauptthemen laut MEDLINE: Anti-Obesity Agents, Obesity, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Obesity AgentsObesityGlucagon-Like Peptide-1 Receptor AgonistsAdultHumansWeight LossTirzepatide

Substanzen

Anti-Obesity AgentsTirzepatideGlucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes, and Metabolism, Weill Cornell Medical College, New York, New York.

Zitieren

APA

Aronne, L. J., & SURMOUNT-4 Investigators (2024). Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity—Reply. JAMA, 331(19), 1676. https://doi.org/10.1001/jama.2024.2603

Vancouver

Aronne LJ, SURMOUNT-4 Investigators. Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity—Reply. JAMA. 2024;331(19):1676. doi:10.1001/jama.2024.2603

BibTeX
@article{Aronne2024,
  author = {Aronne, Louis J and SURMOUNT-4 Investigators, SURMOUNT-4 Investigators},
  title = {Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity—Reply},
  journal = {JAMA},
  year = {2024},
  volume = {331},
  number = {19},
  pages = {1676},
  doi = {10.1001/jama.2024.2603}
}
Kostenlos starten →